# Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai

> **NCT02238912** · PHASE2 · COMPLETED · sponsor: **National institute of Siddha** · enrollment: 50 (actual)

## Conditions studied

- Tinea Infections Such as Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Mannum, Tinea Barbae, Tinea Capitis Are Studied

## Interventions

- **DRUG:** kandhaga rasayanam

## Key facts

- **NCT ID:** NCT02238912
- **Lead sponsor:** National institute of Siddha
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2014-04
- **Final completion:** —
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02238912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02238912, "Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02238912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*